TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers
Clinical trial NCT01288677 · COMPLETED
Trial details
- NCT number
- NCT01288677
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-06-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.